Hofseth Biocare ASA (HBC) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.167x

Based on the latest financial reports, Hofseth Biocare ASA (HBC) has a cash flow conversion efficiency ratio of 0.167x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-4.65 Million ≈ $-489.52K USD) by net assets (Nkr-27.85 Million ≈ $-2.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hofseth Biocare ASA defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Hofseth Biocare ASA - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Hofseth Biocare ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hofseth Biocare ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hofseth Biocare ASA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
EQ Inc.
V:EQ
0.334x
Hvidbjerg Bank
CO:HVID
0.002x
SMCore.Inc
KQ:007820
-0.082x
PBG S.A
SA:PTBL3
0.090x
Francotyp-Postalia Holding AG
F:FPH
0.005x
DK-Lok Corporation
KQ:105740
0.012x
Avrot Industries Ltd
TA:AVRT
0.029x
Adveritas Ltd
AU:AV1
-1.106x

Annual Cash Flow Conversion Efficiency for Hofseth Biocare ASA (2010–2024)

The table below shows the annual cash flow conversion efficiency of Hofseth Biocare ASA from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Hofseth Biocare ASA (HBC) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Nkr61.30 Million
≈ $6.45 Million
Nkr-9.78 Million
≈ $-1.03 Million
-0.160x -337.71%
2023-12-31 Nkr41.14 Million
≈ $4.33 Million
Nkr2.76 Million
≈ $290.54K
0.067x +121.99%
2022-12-31 Nkr148.03 Million
≈ $15.58 Million
Nkr-45.17 Million
≈ $-4.75 Million
-0.305x +30.67%
2021-12-31 Nkr140.38 Million
≈ $14.77 Million
Nkr-61.78 Million
≈ $-6.50 Million
-0.440x -88.34%
2020-12-31 Nkr263.76 Million
≈ $27.76 Million
Nkr-61.63 Million
≈ $-6.49 Million
-0.234x +11.42%
2019-12-31 Nkr117.75 Million
≈ $12.39 Million
Nkr-31.06 Million
≈ $-3.27 Million
-0.264x +20.71%
2018-12-31 Nkr86.04 Million
≈ $9.05 Million
Nkr-28.62 Million
≈ $-3.01 Million
-0.333x +51.59%
2017-12-31 Nkr37.08 Million
≈ $3.90 Million
Nkr-25.48 Million
≈ $-2.68 Million
-0.687x +45.24%
2016-12-31 Nkr53.56 Million
≈ $5.64 Million
Nkr-67.23 Million
≈ $-7.07 Million
-1.255x -612.71%
2015-12-31 Nkr32.55 Million
≈ $3.42 Million
Nkr7.97 Million
≈ $838.36K
0.245x +131.04%
2014-12-31 Nkr78.95 Million
≈ $8.31 Million
Nkr-62.26 Million
≈ $-6.55 Million
-0.789x +41.55%
2013-12-31 Nkr62.00 Million
≈ $6.52 Million
Nkr-83.65 Million
≈ $-8.80 Million
-1.349x -34.11%
2012-12-31 Nkr47.72 Million
≈ $5.02 Million
Nkr-48.01 Million
≈ $-5.05 Million
-1.006x -522.78%
2011-12-31 Nkr120.53 Million
≈ $12.68 Million
Nkr-19.47 Million
≈ $-2.05 Million
-0.162x +1.39%
2010-12-31 Nkr75.97 Million
≈ $7.99 Million
Nkr-12.45 Million
≈ $-1.31 Million
-0.164x --

About Hofseth Biocare ASA

OL:HBC Norway Packaged Foods
Market Cap
$47.81 Million
Nkr454.34 Million NOK
Market Cap Rank
#22165 Global
#197 in Norway
Share Price
Nkr1.15
Change (1 day)
-2.13%
52-Week Range
Nkr1.12 - Nkr2.08
All Time High
Nkr10.95
About

Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a salmon oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are ca… Read more